ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
27 hedge funds and large institutions have $9.01M invested in Acura Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
27
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$31K | |
| 2 | +$29.6K | |
| 3 | +$1.51K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$453 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$255 |
Top Sellers
| 1 | -$45K | |
| 2 | -$30K | |
| 3 | -$20K | |
| 4 |
Goldman Sachs
New York
|
-$19K |
| 5 |
Mariner
Overland Park,
Kansas
|
-$8.51K |